[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

EMEA (Europe, Middle East and Africa) Granulocyte Macrophage Colony Stimulating Factor Market Report 2017

December 2017 | 101 pages | ID: E90964BB3E7EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the EMEA Granulocyte Macrophage Colony Stimulating Factor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Granulocyte Macrophage Colony Stimulating Factor for these regions, from 2012 to 2022 (forecast)
  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Granulocyte Macrophage Colony Stimulating Factor market competition by top manufacturers/players, with Granulocyte Macrophage Colony Stimulating Factor sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Aduro BioTech Inc
  • Amgen Inc
  • BriaCell Therapeutics Corp
  • Cold Genesys Inc
  • GlaxoSmithKline Plc
  • Humanigen Inc
  • Mologen AG
  • Morphotek Inc
  • Sillajen Biotherapeutics
  • Takeda Pharmaceutical Co Ltd
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • CG-0070
  • Gimsilumab
  • GSK-3196165
  • Lenzilumab
  • MGN-1601
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Solid Tumor
  • Lymphoma
  • Kidney Cancer
  • Lung Disease
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
EMEA (Europe, Middle East and Africa) Granulocyte Macrophage Colony Stimulating Factor Market Report 2017

1 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR OVERVIEW

1.1 Product Overview and Scope of Granulocyte Macrophage Colony Stimulating Factor
1.2 Classification of Granulocyte Macrophage Colony Stimulating Factor
  1.2.1 EMEA Granulocyte Macrophage Colony Stimulating Factor Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Granulocyte Macrophage Colony Stimulating Factor Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 CG-0070
  1.2.4 Gimsilumab
  1.2.5 GSK-3196165
  1.2.6 Lenzilumab
  1.2.7 MGN-1601
  1.2.8 Others
1.3 EMEA Granulocyte Macrophage Colony Stimulating Factor Market by Application/End Users
  1.3.1 EMEA Granulocyte Macrophage Colony Stimulating Factor Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Solid Tumor
  1.3.3 Lymphoma
  1.3.4 Kidney Cancer
  1.3.5 Lung Disease
  1.3.6 Others
1.4 EMEA Granulocyte Macrophage Colony Stimulating Factor Market by Region
  1.4.1 EMEA Granulocyte Macrophage Colony Stimulating Factor Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Granulocyte Macrophage Colony Stimulating Factor (2012-2022)
  1.5.1 EMEA Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2012-2022)

2 EMEA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Granulocyte Macrophage Colony Stimulating Factor Market Competition by Players/Manufacturers
  2.1.1 EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Granulocyte Macrophage Colony Stimulating Factor Sale Price by Players (2012-2017)
2.2 EMEA Granulocyte Macrophage Colony Stimulating Factor (Volume and Value) by Type/Product Category
  2.2.1 EMEA Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Granulocyte Macrophage Colony Stimulating Factor Sale Price by Type (2012-2017)
2.3 EMEA Granulocyte Macrophage Colony Stimulating Factor (Volume) by Application
2.4 EMEA Granulocyte Macrophage Colony Stimulating Factor (Volume and Value) by Region
  2.4.1 EMEA Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Price by Region (2012-2017)

3 EUROPE GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales and Value (2012-2017)
  3.1.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2012-2017)
3.2 Europe Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Type
3.3 Europe Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Application
3.4 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume by Countries (2012-2017)
  3.4.2 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2012-2017)
  3.4.3 Germany Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  3.4.4 France Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  3.4.5 UK Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  3.4.6 Russia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  3.4.7 Italy Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)

4 MIDDLE EAST GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Granulocyte Macrophage Colony Stimulating Factor Sales and Value (2012-2017)
  4.1.1 Middle East Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2012-2017)
4.2 Middle East Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Type
4.3 Middle East Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Application
4.4 Middle East Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Granulocyte Macrophage Colony Stimulating Factor Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  4.4.4 Israel Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  4.4.5 UAE Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  4.4.6 Iran Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)

5 AFRICA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Granulocyte Macrophage Colony Stimulating Factor Sales and Value (2012-2017)
  5.1.1 Africa Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2012-2017)
5.2 Africa Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Type
5.3 Africa Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Application
5.4 Africa Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Granulocyte Macrophage Colony Stimulating Factor Sales Volume by Countries (2012-2017)
  5.4.2 Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2012-2017)
  5.4.3 South Africa Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2012-2017)

6 EMEA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Aduro BioTech Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Granulocyte Macrophage Colony Stimulating Factor Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Amgen Inc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Granulocyte Macrophage Colony Stimulating Factor Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 BriaCell Therapeutics Corp
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Granulocyte Macrophage Colony Stimulating Factor Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Cold Genesys Inc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Granulocyte Macrophage Colony Stimulating Factor Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline Plc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Granulocyte Macrophage Colony Stimulating Factor Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Humanigen Inc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Granulocyte Macrophage Colony Stimulating Factor Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Mologen AG
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Granulocyte Macrophage Colony Stimulating Factor Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Morphotek Inc
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Granulocyte Macrophage Colony Stimulating Factor Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Sillajen Biotherapeutics
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Granulocyte Macrophage Colony Stimulating Factor Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Takeda Pharmaceutical Co Ltd
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Granulocyte Macrophage Colony Stimulating Factor Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MANUFACTURING COST ANALYSIS

7.1 Granulocyte Macrophage Colony Stimulating Factor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Granulocyte Macrophage Colony Stimulating Factor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Granulocyte Macrophage Colony Stimulating Factor Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET FORECAST (2017-2022)

11.1 EMEA Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Granulocyte Macrophage Colony Stimulating Factor Price and Trend Forecast (2017-2022)
11.2 EMEA Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Type (2017-2022)
11.7 EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Granulocyte Macrophage Colony Stimulating Factor
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Type (Product Category) in 2016
Figure CG-0070 Product Picture
Figure Gimsilumab Product Picture
Figure GSK-3196165 Product Picture
Figure Lenzilumab Product Picture
Figure MGN-1601 Product Picture
Figure Others Product Picture
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor by Application in 2016
Figure Solid Tumor Examples
Table Key Downstream Customer in Solid Tumor
Figure Lymphoma Examples
Table Key Downstream Customer in Lymphoma
Figure Kidney Cancer Examples
Table Key Downstream Customer in Kidney Cancer
Figure Lung Disease Examples
Table Key Downstream Customer in Lung Disease
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Market Size (Million USD) by Region (2012-2022)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) Status and Forecast by Countries
Figure Africa Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2012-2022)
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Share by Players (2012-2017)
Figure 2016 Granulocyte Macrophage Colony Stimulating Factor Sales Share by Players
Figure 2017 Granulocyte Macrophage Colony Stimulating Factor Sales Share by Players
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) by Players (2012-2017)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Players (2012-2017)
Table 2016 EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Players
Table 2017 EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Players
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Share by Type (2012-2017)
Figure Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor by Type (2012-2017)
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2012-2017)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Granulocyte Macrophage Colony Stimulating Factor by Type in 2016
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Share by Application (2012-2017)
Figure Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor by Application (2012-2017)
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application in 2016
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Share by Region (2012-2017)
Figure Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor by Region (2012-2017)
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in 2016
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Granulocyte Macrophage Colony Stimulating Factor by Region (2012-2017)
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Regions in 2016
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2012-2017)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) by Type (2012-2017)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Market Share by Type (2012-2017)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Market Share by Type in 2016
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) by Application (2012-2017)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Market Share by Application (2012-2017)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Market Share by Application in 2016
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) by Countries (2012-2017)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2012-2017)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2012-2017)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries in 2016
Table Europe Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) by Countries (2012-2017)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2012-2017)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2012-2017)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries in 2016
Figure Germany Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) by Type (2012-2017)
Table Middle East Granulocyte Macrophage Colony Stimulating Factor Market Share by Type (2012-2017)
Figure Middle East Granulocyte Macrophage Colony Stimulating Factor Market Share by Type (2012-2017)
Table Middle East Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) by Applications (2012-2017)
Table Middle East Granulocyte Macrophage Colony Stimulating Factor Market Share by Applications (2012-2017)
Figure Middle East Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application in 2016
Table Middle East Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Granulocyte Macrophage Colony Stimulating Factor Sales Volume Market Share by Countries in 2016
Table Middle East Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) by Countries (2012-2017)
Table Middle East Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2012-2017)
Figure Middle East Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2012-2017)
Figure Middle East Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries in 2016
Figure Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) by Type (2012-2017)
Table Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2012-2017)
Figure Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2012-2017)
Figure Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type in 2016
Table Africa Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) by Application (2012-2017)
Table Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2012-2017)
Figure Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2012-2017)
Table Africa Granulocyte Macrophage Colony Stimulating Factor Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2012-2017)
Figure Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2012-2017)
Figure Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries in 2016
Table Africa Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) by Countries (2012-2017)
Table Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2012-2017)
Figure Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2012-2017)
Figure Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries in 2016
Figure South Africa Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Table Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information List
Table Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information List
Table Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Basic Information List
Table BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information List
Table Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Basic Information List
Table GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information List
Table Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Mologen AG Granulocyte Macrophage Colony Stimulating Factor Basic Information List
Table Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Mologen AG Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information List
Table Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Basic Information List
Table Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Basic Information List
Table Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Granulocyte Macrophage Colony Stimulating Factor
Figure Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor
Figure Granulocyte Macrophage Colony Stimulating Factor Industrial Chain Analysis
Table Raw Materials Sources of Granulocyte Macrophage Colony Stimulating Factor Major Manufacturers in 2016
Table Major Buyers of Granulocyte Macrophage Colony Stimulating Factor
Table Distributors/Traders List
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Region (2017-2022)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Region (2017-2022)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Countries (2017-2022)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Countries (2017-2022)
Table Africa Granulocyte Macrophage Colony Stimulating Factor Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Type (2017-2022)
Table EMEA Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories